Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis

Completed

Conditions studied: Plaque Psoriasis

In brief

To estimate the real-world effectiveness of approved biologics in subjects with moderate-to-severe plaque psoriasis who are either starting or switching biologic medication.

Key facts

Study ID
NCT02239666
Run by
AstraZeneca
People needed
899
Starts
2014-03-01
Expected to finish
2017-01-05
Last updated by the study team
2017-08-03

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.